The 50 Most-Frequently Read Articles
in J Clin Oncol during October 2009 -- updated monthly

Most-read rankings are recalculated at the beginning of the month and are based on full-text and pdf views.

1.	Mark G. Kris, Paul J. Hesketh, Mark R. Somerfield, Petra Feyer, Rebecca Clark-Snow, James M. Koeller, Gary R. Morrow, Lawrence W. Chinnery, Maurice J. Chesney, Richard J. Gralla, Steven M. Grunberg
		American Society of Clinical Oncology Guideline for Antiemetics in Oncology: Update 2006
		J. Clin. Oncol. Jun 20, 2006; 24: 2932-2947. (In "ASCO SPECIAL ARTICLES")   [Abstract]     [Full Text]     [PDF]
2.	Giorgio Vittorio Scagliotti, Purvish Parikh, Joachim von Pawel, Bonne Biesma, Johan Vansteenkiste, Christian Manegold, Piotr Serwatowski, Ulrich Gatzemeier, Raghunadharao Digumarti, Mauro Zukin, Jin S. Lee, Anders Mellemgaard, Keunchil Park, Shehkar Patil, Janusz Rolski, Tuncay Goksel, Filippo de Marinis, Lorinda Simms, Katherine P. Sugarman, David Gandara
		Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
		J. Clin. Oncol. Jul 20, 2008; 26: 3543-3551. (In "Thoracic Oncology")   [Abstract]     [Full Text]     [PDF]
3.	Anja Rinke, Hans-Helge Müller, Carmen Schade-Brittinger, Klaus-Jochen Klose, Peter Barth, Matthias Wied, Christina Mayer, Behnaz Aminossadati, Ulrich-Frank Pape, Michael Bläker, Jan Harder, Christian Arnold, Thomas Gress, Rudolf Arnold
		Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
		J. Clin. Oncol. Oct 01, 2009; 27: 4656-4663. (In "Gastrointestinal Cancer")   [Abstract]     [Full Text]     [PDF]
4.	Gary H. Lyman, Alok A. Khorana
		Cancer, Clots and Consensus: New Understanding of an Old Problem
		J. Clin. Oncol. Oct 10, 2009; 27: 4821-4826. (In "Overview")   [Full Text]     [PDF]
5.	Alok A. Khorana, Michael B. Streiff, Dominique Farge, Mario Mandala, Philippe Debourdeau, Francis Cajfinger, Michel Marty, Anna Falanga, Gary H. Lyman
		Venous Thromboembolism Prophylaxis and Treatment in Cancer: A Consensus Statement of Major Guidelines Panels and Call to Action
		J. Clin. Oncol. Oct 10, 2009; 27: 4919-4926. (In "REVIEW ARTICLES")   [Abstract]     [Full Text]     [PDF]
6.	Luca Gianni, Larry Norton, Norman Wolmark, Thomas M. Suter, Gianni Bonadonna, Gabriel N. Hortobagyi
		Role of Anthracyclines in the Treatment of Early Breast Cancer
		J. Clin. Oncol. Oct 01, 2009; 27: 4798-4808. (In "REVIEW ARTICLES")   [Abstract]     [Full Text]     [PDF]
7.	Lyndsay Harris, Herbert Fritsche, Robert Mennel, Larry Norton, Peter Ravdin, Sheila Taube, Mark R. Somerfield, Daniel F. Hayes, Robert C. Bast
		American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
		J. Clin. Oncol. Nov 20, 2007; 25: 5287-5312. (In "ASCO SPECIAL ARTICLES")   [Abstract]     [Full Text]     [PDF]
8.	Henry S. Friedman, Michael D. Prados, Patrick Y. Wen, Tom Mikkelsen, David Schiff, Lauren E. Abrey, W.K. Alfred Yung, Nina Paleologos, Martin K. Nicholas, Randy Jensen, James Vredenburgh, Jane Huang, Maoxia Zheng, Timothy Cloughesy
		Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
		J. Clin. Oncol. Oct 01, 2009; 27: 4733-4740. (In "Neurooncology")   [Abstract]     [Full Text]     [PDF]
9.	Shannon MacDonald, Alphonse G. Taghian
		Prognostic Factors for Local Control After Breast Conservation: Does Margin Status Still Matter?
		J. Clin. Oncol. Oct 20, 2009; 27: 4929-4930. (In "EDITORIALS")   [Full Text]     [PDF]
10.	Robert Gray, Suman Bhattacharya, Christopher Bowden, Kathy Miller, Robert L. Comis
		Independent Review of E2100: A Phase III Trial of Bevacizumab Plus Paclitaxel Versus Paclitaxel in Women With Metastatic Breast Cancer
		J. Clin. Oncol. Oct 20, 2009; 27: 4966-4972. (In "Breast Cancer")   [Abstract]     [Full Text]     [PDF]
11.	Kjell E. Öberg
		Is It Time to Widen the Use of Somatostatin Analogs in Neuroendocrine Tumors?
		J. Clin. Oncol. Oct 01, 2009; 27: 4635-4636. (In "EDITORIALS")   [Full Text]     [PDF]
12.	Maurizio Zangari, Louis M. Fink, Francesca Elice, Fenghuang Zhan, Dorothy M. Adcock, Guido J. Tricot
		Thrombotic Events in Patients With Cancer Receiving Antiangiogenesis Agents
		J. Clin. Oncol. Oct 10, 2009; 27: 4865-4873. (In "REVIEW ARTICLES")   [Abstract]     [Full Text]     [PDF]
13.	Rowan T. Chlebowski
		Aromatase Inhibitor–Associated Arthralgias
		J. Clin. Oncol. Oct 20, 2009; 27: 4932-4934. (In "EDITORIALS")   [Full Text]     [PDF]
14.	Joseph O. Jacobson, Martha Polovich, Kristen K. McNiff, Kristine B. LeFebvre, Charmaine Cummings, Michele Galioto, Katherine R. Bonelli, Michele R. McCorkle
		American Society of Clinical Oncology/Oncology Nursing Society Chemotherapy Administration Safety Standards
		J. Clin. Oncol. Sep 28, 2009; doi: 10.1200/JCO.2009.25.1264. (In "ASCO SPECIAL ARTICLES")   [Abstract]     [PDF]
15.	Heather A. Jones, Ninja Antonini, Augustinus A.M. Hart, Johannes L. Peterse, Jean-Claude Horiot, Françoise Collin, Philip M. Poortmans, S. Bing Oei, Laurence Collette, Henk Struikmans, Walter F. Van den Bogaert, Alain Fourquet, Jos J. Jager, Dominic A.X. Schinagl, Carla C. Wárlám-Rodenhuis, Harry Bartelink
		Impact of Pathological Characteristics on Local Relapse After Breast-Conserving Therapy: A Subgroup Analysis of the EORTC Boost Versus No Boost Trial
		J. Clin. Oncol. Oct 20, 2009; 27: 4939-4947. (In "Breast Cancer")   [Abstract]     [Full Text]     [PDF]
16.	Nora M. Hansen, Baiba Grube, Xing Ye, Roderick R. Turner, R. James Brenner, Myung-Shin Sim, Armando E. Giuliano
		Impact of Micrometastases in the Sentinel Node of Patients With Invasive Breast Cancer
		J. Clin. Oncol. Oct 01, 2009; 27: 4679-4684. (In "Breast Cancer")   [Abstract]     [Full Text]     [PDF]
17.	Alok A. Khorana, Gregory C. Connolly
		Assessing Risk of Venous Thromboembolism in the Patient With Cancer
		J. Clin. Oncol. Oct 10, 2009; 27: 4839-4847. (In "REVIEW ARTICLES")   [Abstract]     [Full Text]     [PDF]
18.	Mark A. Socinski, Egbert F. Smit, Paul Lorigan, Kartik Konduri, Martin Reck, Aleksandra Szczesna, Johnetta Blakely, Piotr Serwatowski, Nina A. Karaseva, Tudor Ciuleanu, Jacek Jassem, Mircea Dediu, Shengyan Hong, Carla Visseren-Grul, Axel-Rainer Hanauske, Coleman K. Obasaju, Susan C. Guba, Nick Thatcher
		Phase III Study of Pemetrexed Plus Carboplatin Compared With Etoposide Plus Carboplatin in Chemotherapy-Naive Patients With Extensive-Stage Small-Cell Lung Cancer
		J. Clin. Oncol. Oct 01, 2009; 27: 4787-4792. (In "Thoracic Oncology")   [Abstract]     [Full Text]     [PDF]
19.	Leora Horn, William Pao
		EML4-ALK: Honing In on a New Target in Non–Small-Cell Lung Cancer
		J. Clin. Oncol. Sep 10, 2009; 27: 4232-4235. (In "EDITORIALS")   [Full Text]     [PDF]
20.	Anthony Zietman
		Evidence-Based Medicine, Conscience-Based Medicine, and the Management of Low-Risk Prostate Cancer
		J. Clin. Oncol. Oct 20, 2009; 27: 4935-4936. (In "EDITORIALS")   [Full Text]     [PDF]
21.	Alice T. Shaw, Beow Y. Yeap, Mari Mino-Kenudson, Subba R. Digumarthy, Daniel B. Costa, Rebecca S. Heist, Benjamin Solomon, Hannah Stubbs, Sonal Admane, Ultan McDermott, Jeffrey Settleman, Susumu Kobayashi, Eugene J. Mark, Scott J. Rodig, Lucian R. Chirieac, Eunice L. Kwak, Thomas J. Lynch, A. John Iafrate
		Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK
		J. Clin. Oncol. Sep 10, 2009; 27: 4247-4253. (In "Thoracic Oncology")   [Abstract]     [Full Text]     [PDF]
22.	Sudeep P. Shivakumar, David R. Anderson, Stephen Couban
		Catheter-Associated Thrombosis in Patients With Malignancy
		J. Clin. Oncol. Oct 10, 2009; 27: 4858-4864. (In "REVIEW ARTICLES")   [Abstract]     [Full Text]     [PDF]
23.	Agnes Y.Y. Lee
		Anticoagulation in the Treatment of Established Venous Thromboembolism in Patients With Cancer
		J. Clin. Oncol. Oct 10, 2009; 27: 4895-4901. (In "REVIEW ARTICLES")   [Abstract]     [Full Text]     [PDF]
24.	William H. Allum, Sally P. Stenning, John Bancewicz, Peter I. Clark, Ruth E. Langley
		Long-Term Results of a Randomized Trial of Surgery With or Without Preoperative Chemotherapy in Esophageal Cancer
		J. Clin. Oncol. Oct 20, 2009; 27: 5062-5067. (In "Gastrointestinal Cancer")   [Abstract]     [Full Text]     [PDF]
25.	Bruce D. Cheson, Beate Pfistner, Malik E. Juweid, Randy D. Gascoyne, Lena Specht, Sandra J. Horning, Bertrand Coiffier, Richard I. Fisher, Anton Hagenbeek, Emanuele Zucca, Steven T. Rosen, Sigrid Stroobants, T. Andrew Lister, Richard T. Hoppe, Martin Dreyling, Kensei Tobinai, Julie M. Vose, Joseph M. Connors, Massimo Federico, Volker Diehl
		Revised Response Criteria for Malignant Lymphoma
		J. Clin. Oncol. Feb 10, 2007; 25: 579-586. (In "SPECIAL ARTICLES")   [Abstract]     [Full Text]     [PDF]
26.	Gary H. Lyman, Alok A. Khorana, Anna Falanga, Daniel Clarke-Pearson, Christopher Flowers, Mohammad Jahanzeb, Ajay Kakkar, Nicole M. Kuderer, Mark N. Levine, Howard Liebman, David Mendelson, Gary Raskob, Mark R. Somerfield, Paul Thodiyil, David Trent, Charles W. Francis
		American Society of Clinical Oncology Guideline: Recommendations for Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer
		J. Clin. Oncol. Dec 01, 2007; 25: 5490-5505. (In "ASCO SPECIAL ARTICLES")   [Abstract]     [Full Text]     [PDF]
27.	Anna Falanga, Marina Marchetti
		Venous Thromboembolism in the Hematologic Malignancies
		J. Clin. Oncol. Oct 10, 2009; 27: 4848-4857. (In "REVIEW ARTICLES")   [Abstract]     [Full Text]     [PDF]
28.	Michael B. Streiff
		Diagnosis and Initial Treatment of Venous Thromboembolism in Patients With Cancer
		J. Clin. Oncol. Oct 10, 2009; 27: 4889-4894. (In "REVIEW ARTICLES")   [Abstract]     [Full Text]     [PDF]
29.	Sergio Pecorelli, Giuseppe Favalli, Angiolo Gadducci, Dionyssios Katsaros, Pierluigi Benedetti Panici, Amalia Carpi, Giovanni Scambia, Michela Ballardini, Oriana Nanni, PierFranco Conte
		Phase III Trial of Observation Versus Six Courses of Paclitaxel in Patients With Advanced Epithelial Ovarian Cancer in Complete Response After Six Courses of Paclitaxel/Platinum-Based Chemotherapy: Final Results of the After-6 Protocol 1
		J. Clin. Oncol. Oct 01, 2009; 27: 4642-4648. (In "Gynecologic Cancer")   [Abstract]     [Full Text]     [PDF]
30.	Kala Visvanathan, Rowan T. Chlebowski, Patricia Hurley, Nananda F. Col, Mary Ropka, Deborah Collyar, Monica Morrow, Carolyn Runowicz, Kathleen I. Pritchard, Karen Hagerty, Banu Arun, Judy Garber, Victor G. Vogel, James L. Wade, Powel Brown, Jack Cuzick, Barnett S. Kramer, Scott M. Lippman
		American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Pharmacologic Interventions Including Tamoxifen, Raloxifene, and Aromatase Inhibition for Breast Cancer Risk Reduction
		J. Clin. Oncol. Jul 01, 2009; 27: 3235-3258. (In "ASCO SPECIAL ARTICLES")   [Abstract]     [Full Text]     [PDF]
31.	Bruce D. Minsky
		Is Preoperative Chemoradiotherapy Still the Treatment of Choice for Rectal Cancer?
		J. Clin. Oncol. Nov 01, 2009; 27: 5115-5116. (In "EDITORIALS")   [Full Text]     [PDF]
32.	David L. Page, Jean F. Simpson
		What Is Atypical Lobular Hyperplasia and What Does It Mean for the Patient?
		J. Clin. Oncol. Aug 20, 2005; 23: 5432-5433. (In "EDITORIALS")   [Full Text]     [PDF]
33.	Carla Boccaccio, Paolo M. Comoglio
		Genetic Link Between Cancer and Thrombosis
		J. Clin. Oncol. Oct 10, 2009; 27: 4827-4833. (In "REVIEW ARTICLES")   [Abstract]     [Full Text]     [PDF]
34.	Tony S.K. Mok, Yi-Long Wu, Chong-Jen Yu, Caicun Zhou, Yuh-Min Chen, Li Zhang, Jorge Ignacio, Meilin Liao, Vichien Srimuninnimit, Michael J. Boyer, Marina Chua-Tan, Virote Sriuranpong, Aru W. Sudoyo, Kate Jin, Michael Johnston, Winsome Chui, Jin-Soo Lee
		Randomized, Placebo-Controlled, Phase II Study of Sequential Erlotinib and Chemotherapy As First-Line Treatment for Advanced Non–Small-Cell Lung Cancer
		J. Clin. Oncol. Oct 20, 2009; 27: 5080-5087. (In "Thoracic Oncology")   [Abstract]     [Full Text]     [PDF]
35.	Malcolm J. Moore, David Goldstein, John Hamm, Arie Figer, Joel R. Hecht, Steven Gallinger, Heather J. Au, Pawel Murawa, David Walde, Robert A. Wolff, Daniel Campos, Robert Lim, Keyue Ding, Gary Clark, Theodora Voskoglou-Nomikos, Mieke Ptasynski, Wendy Parulekar
		Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
		J. Clin. Oncol. May 20, 2007; 25: 1960-1966. (In "Gastrointestinal Cancer")   [Abstract]     [Full Text]     [PDF]
36.	Thomas J. Smith, James Khatcheressian, Gary H. Lyman, Howard Ozer, James O. Armitage, Lodovico Balducci, Charles L. Bennett, Scott B. Cantor, Jeffrey Crawford, Scott J. Cross, George Demetri, Christopher E. Desch, Philip A. Pizzo, Charles A. Schiffer, Lee Schwartzberg, Mark R. Somerfield, George Somlo, James C. Wade, James L. Wade, Rodger J. Winn, Antoinette J. Wozniak, Antonio C. Wolff
		2006 Update of Recommendations for the Use of White Blood Cell Growth Factors: An Evidence-Based Clinical Practice Guideline
		J. Clin. Oncol. Jul 01, 2006; 24: 3187-3205. (In "ASCO SPECIAL ARTICLES")   [Abstract]     [Full Text]     [PDF]
37.	Bertrand Coiffier, Arnold Altman, Ching-Hon Pui, Anas Younes, Mitchell S. Cairo
		Guidelines for the Management of Pediatric and Adult Tumor Lysis Syndrome: An Evidence-Based Review
		J. Clin. Oncol. Jun 01, 2008; 26: 2767-2778. (In "REVIEW ARTICLES")   [Abstract]     [Full Text]     [PDF]
38.	Charles W. Francis
		Prevention of Venous Thromboembolism in Hospitalized Patients With Cancer
		J. Clin. Oncol. Oct 10, 2009; 27: 4874-4880. (In "REVIEW ARTICLES")   [Abstract]     [Full Text]     [PDF]
39.	William Patrick McGuire
		Maintenance Therapy for Ovarian Cancer: Of Helsinki and Hippocrates
		J. Clin. Oncol. Oct 01, 2009; 27: 4633-4634. (In "EDITORIALS")   [Full Text]     [PDF]
40.	Bradley J. Monk, Michael W. Sill, D. Scott McMeekin, David E. Cohn, Lois M. Ramondetta, Cecelia H. Boardman, Jo Benda, David Cella
		Phase III Trial of Four Cisplatin-Containing Doublet Combinations in Stage IVB, Recurrent, or Persistent Cervical Carcinoma: A Gynecologic Oncology Group Study
		J. Clin. Oncol. Oct 01, 2009; 27: 4649-4655. (In "Gynecologic Cancer")   [Abstract]     [Full Text]     [PDF]
41.	Stephen Johnston, John Pippen, Xavier Pivot, Mikhail Lichinitser, Saeed Sadeghi, Veronique Dieras, Henry Leonidas Gomez, Gilles Romieu, Alexey Manikhas, M. John Kennedy, Michael F. Press, Julie Maltzman, Allison Florance, Lisa O''Rourke, Cristina Oliva, Steven Stein, Mark Pegram
		Lapatinib Combined With Letrozole Versus Letrozole and Placebo As First-Line Therapy for Postmenopausal Hormone Receptor–Positive Metastatic Breast Cancer
		J. Clin. Oncol. Sep 28, 2009; doi: 10.1200/JCO.2009.23.3734. (In "Breast Cancer")   [Abstract]     [PDF]
42.	Raj S. Kasthuri, Mark B. Taubman, Nigel Mackman
		Role of Tissue Factor in Cancer
		J. Clin. Oncol. Oct 10, 2009; 27: 4834-4838. (In "REVIEW ARTICLES")   [Abstract]     [Full Text]     [PDF]
43.	Thierry André, Corrado Boni, Matilde Navarro, Josep Tabernero, Tamas Hickish, Clare Topham, Andrea Bonetti, Philip Clingan, John Bridgewater, Fernando Rivera, Aimery de Gramont
		Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial
		J. Clin. Oncol. Jul 01, 2009; 27: 3109-3116. (In "Gastrointestinal Cancer")   [Abstract]     [Full Text]     [PDF]
44.	Bella Kaufman, John R. Mackey, Michael R. Clemens, Poonamalle P. Bapsy, Ashok Vaid, Andrew Wardley, Sergei Tjulandin, Michaela Jahn, Michaela Lehle, Andrea Feyereislova, Cédric Révil, Alison Jones
		Trastuzumab Plus Anastrozole Versus Anastrozole Alone for the Treatment of Postmenopausal Women With Human Epidermal Growth Factor Receptor 2–Positive, Hormone Receptor–Positive Metastatic Breast Cancer: Results From the Randomized Phase III TAnDEM Study
		J. Clin. Oncol. Sep 28, 2009; doi: 10.1200/JCO.2008.20.6847. (In "Breast Cancer")   [Abstract]     [PDF]
45.	Stephen B. Edge
		Nipple-Sparing Mastectomy: How Often Is the Nipple Involved?
		J. Clin. Oncol. Oct 20, 2009; 27: 4930-4932. (In "EDITORIALS")   [Full Text]     [PDF]
46.	Luca Malcovati, Matteo Giovanni Della Porta, Cristiana Pascutto, Rosangela Invernizzi, Marina Boni, Erica Travaglino, Francesco Passamonti, Luca Arcaini, Margherita Maffioli, Paolo Bernasconi, Mario Lazzarino, Mario Cazzola
		Prognostic Factors and Life Expectancy in Myelodysplastic Syndromes Classified According to WHO Criteria: A Basis for Clinical Decision Making
		J. Clin. Oncol. Oct 20, 2005; 23: 7594-7603. (In "Hematologic Malignancies")   [Abstract]     [Full Text]     [PDF]
47.	Antonio C. Wolff, M. Elizabeth H. Hammond, Jared N. Schwartz, Karen L. Hagerty, D. Craig Allred, Richard J. Cote, Mitchell Dowsett, Patrick L. Fitzgibbons, Wedad M. Hanna, Amy Langer, Lisa M. McShane, Soonmyung Paik, Mark D. Pegram, Edith A. Perez, Michael F. Press, Anthony Rhodes, Catharine Sturgeon, Sheila E. Taube, Raymond Tubbs, Gail H. Vance, Marc van de Vijver, Thomas M. Wheeler, Daniel F. Hayes
		American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer
		J. Clin. Oncol. Jan 01, 2007; 25: 118-145. (In "ASCO SPECIAL ARTICLES")   [Abstract]     [Full Text]     [PDF]
48.	Mark N. Levine
		New Antithrombotic Drugs: Potential for Use in Oncology
		J. Clin. Oncol. Oct 10, 2009; 27: 4912-4918. (In "REVIEW ARTICLES")   [Abstract]     [Full Text]     [PDF]
49.	Robert J. Motzer, Thomas E. Hutson, Piotr Tomczak, M. Dror Michaelson, Ronald M. Bukowski, Stéphane Oudard, Sylvie Negrier, Cezary Szczylik, Roberto Pili, Georg A. Bjarnason, Xavier Garcia-del-Muro, Jeffrey A. Sosman, Ewa Solska, George Wilding, John A. Thompson, Sindy T. Kim, Isan Chen, Xin Huang, Robert A. Figlin
		Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma
		J. Clin. Oncol. Aug 01, 2009; 27: 3584-3590. (In "Genitourinary Cancer")   [Abstract]     [Full Text]     [PDF]
50.	Nasser Hanna, Frances A. Shepherd, Frank V. Fossella, Jose R. Pereira, Filippo De Marinis, Joachim von Pawel, Ulrich Gatzemeier, Thomas Chang Yao Tsao, Miklos Pless, Thomas Muller, Hong-Liang Lim, Christopher Desch, Klara Szondy, Radj Gervais, Shaharyar, Christian Manegold, Sofia Paul, Paolo Paoletti, Lawrence Einhorn, Paul A. Bunn
		Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy
		J. Clin. Oncol. May 01, 2004; 22: 1589-1597. (In "Lung Cancer")   [Abstract]     [Full Text]     [PDF]

Subscribe to Most Read feed

Last Updated: 11/07/2009 15:44:41